Sbrt Clinical Trials 2023

Sbrt Clinical Trials 2023

Sbrt research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in sbrt clinical trials today.

Trials for Adenocarcinoma Patients

Trials for NSCLC Patients

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to sbrt

What are the top hospitals conducting sbrt research?

Cutting-edge advancements in the field of radiation therapy are being pioneered by top hospitals across the globe, with a particular focus on Stereotactic Body Radiation Therapy (SBRT). Hospitals such as M D Anderson Cancer Center in Houston are leading the way with six active SBRT trials. Notably, this center has embarked on groundbreaking research to enhance treatment options for patients using SBRT. In Boston, Beth Israel Deaconess Medical Center is also making significant strides, currently conducting four active SBRT trials. The collaboration between researchers and physicians at this esteemed institution aims to revolutionize cancer care through innovative approaches utilizing SBRT technology.

Venturing northward to Edmonton's Cross Cancer Institute reveals another hub of pioneering medical research. With four ongoing clinical trials centered around SBRT, this Canadian institute plays a vital role in advancing knowledge and improving outcomes for patients undergoing radiotherapy treatments. Similarly focused on innovation is Emory University Hospital/Winship Cancer Institute in Atlanta where an equal number of active SBRT trials are underway. By exploring the potential of this cutting-edge technology, these institutions aim to optimize radiation therapy protocols and ultimately improve patient survival rates.

Situated in Hamilton, Canada's Juravinski Cancer Centre completes our list of top hospitals involved in current SBRT trials. This dynamic facility is actively engaged in three clinical studies that harness the power of precise radiation delivery techniques offered by SBRT. Through their commitment to advancing scientific understanding and patient care within oncology treatments like SBRT, these hospitals contribute significantly towards better outcomes for individuals facing various forms of cancer requiring radiation intervention.

Collectively, these world-class medical institutions showcase their unwavering dedication to finding innovative solutions that challenge conventional practices while aiming for improved therapeutic success rates with minimally invasive procedures.

Which are the best cities for sbrt clinical trials?

When it comes to sbrt clinical trials, several cities stand out as hubs of research and development. New york, New York leads the way with 20 active trials exploring treatments like Fractionated Stereotactic Radiosurgery and Pembrolizumab combined with SRS. Boston, Massachusetts closely follows with 19 ongoing studies focused on interventions such as FOLFIRINOX and AGuIX. Houston, Texas is also a notable location with 14 active trials investigating treatments like Stereotactic Radiosurgery and the NovoTTF-200M device. Lastly, Montréal, Quebec offers promising opportunities with 13 active trials studying SBRT and other potential breakthroughs. These cities provide access to cutting-edge sbrt clinical trials that drive innovation in care for patients seeking advanced treatment options.

Which are the top treatments for sbrt being explored in clinical trials?

Stereotactic body radiation therapy (SBRT) is an area of active research, with several promising treatments currently being explored in clinical trials. Among the top contenders are:

  • Daratumumab: Being tested in 6 ongoing SBRT trials
  • Belantamab mafodotin: Under investigation in 4 active SBRT studies
  • Lenalidomide: Currently involved in 3 clinical trials focused on SBRT.
What are the most recent clinical trials for sbrt?

The field of Stereotactic Body Radiation Therapy (SBRT) is witnessing promising advancements through recent clinical trials. One such study focuses on men with low to intermediate risk prostate cancer, evaluating the effectiveness of SBRT as a treatment option. Another trial investigates the application of radiosurgery in SBRT, seeking to determine its potential benefits across different phases. Additionally, cisplatin has emerged as a candidate for use alongside SBRT, offering new possibilities for patient care. Notably, standard dose SBRT and olaparib have also been explored in separate Phase 2 trials, presenting alternative avenues for optimizing treatment outcomes. These ongoing studies hold promise for refining and expanding the role of SBRT in various medical contexts.

What sbrt clinical trials were recently completed?

Recently completed clinical trials in the field of Stereotactic Body Radiation Therapy (SBRT) have made significant contributions to advancing cancer treatment. Notably, a trial investigating the efficacy and safety of SBRT for lung cancer was successfully completed, providing valuable insights into this innovative therapy. The completion of this groundbreaking study marks an important milestone in improving outcomes for patients undergoing radiation therapy for lung cancer.